Antimicrobial Agents — MCQs

Antimicrobial Agents Indian Medical PG Practice Questions and MCQs

Question 361: Which drug can clear trypanosomes from blood and lymph nodes and is active in late Central Nervous System stages of African sleeping sickness?

A. Emetine
B. Melarsoprol (Correct Answer)
C. Nifurtimox
D. Suramin

Explanation: African Trypanosomiasis (Sleeping Sickness) is caused by *Trypanosoma brucei*. The treatment strategy depends on the stage of the disease: the early stage (hemolymphatic) or the late stage (meningoencephalitic) [1]. **1. Why Melarsoprol is Correct:** Melarsoprol is an organic arsenical compound. Its defining pharmacological property is its ability to **cross the blood-brain barrier (BBB)** in therapeutic concentrations. It is the drug of choice for the **late CNS stage** of *T.b. rhodesiense* [1]. It acts by inhibiting trypanosomal enzymes, particularly those involved in glycolysis, effectively clearing parasites from the blood, lymph, and CNS. **2. Why the Other Options are Incorrect:** * **Emetine (A):** An alkaloid used historically for amoebiasis (specifically amoebic liver abscess); it has no role in treating trypanosomiasis [2]. * **Nifurtimox (C):** Primarily used for **Chagas disease** (*T. cruzi*). While it can be used in combination with eflornithine (NECT) for West African sleeping sickness, it is not the classic monotherapy for late-stage *T.b. rhodesiense*. * **Suramin (D):** This drug is highly effective for the **early stage** (hemolymphatic) of *T.b. rhodesiense*. However, it is a large, polar molecule that **cannot cross the BBB**, making it ineffective for late-stage CNS involvement [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Melarsoprol Toxicity:** The most dreaded side effect is **reactive encephalopathy** (seen in 5-10% of patients), which can be fatal [1]. * **Stage-Specific Drugs:** * *Early Stage:* **Suramin** (*rhodesiense*) or **Pentamidine** (*gambiense*). * *Late Stage:* **Melarsoprol** (both) or **Eflornithine** (*gambiense* only) [1]. * **Mnemonic:** "**S**uramin for **S**urface (blood); **M**elarsoprol for **M**enings (CNS)."

Question 362: Which of the following is the most appropriate treatment for a patient with tuberculosis in whom Mycobacterium is resistant to both isoniazid and rifampicin?

A. 6 drugs for 4 months and 4 drugs for 12 months
B. 6 drugs for 6 months and 4 drugs for 18 months (Correct Answer)
C. 6 drugs for 6 months and 4 drugs for 4 months
D. 5 drugs for 2 months, 4 drugs for one month, and 3 drugs for 5 months

Explanation: ### Explanation **Concept: Management of Multidrug-Resistant Tuberculosis (MDR-TB)** The question describes a patient with **MDR-TB**, defined as resistance to at least **Isoniazid (H) and Rifampicin (R)**. These are the two most potent first-line anti-tubercular drugs. When resistance to both occurs, the treatment regimen must be significantly intensified in both duration and the number of drugs used to ensure sterilization and prevent further resistance. **Why Option B is Correct:** According to the WHO and National Tuberculosis Elimination Program (NTEP) guidelines for the **Conventional (Longer) MDR-TB Regimen**: * **Intensive Phase (IP):** Lasts for **6 months**, utilizing at least **6 drugs** (typically including a fluoroquinolone, a second-line injectable, and other second-line agents like ethionamide, cycloserine, or pyrazinamide). * **Continuation Phase (CP):** Lasts for **18 months**, utilizing **4 drugs**. The total duration of treatment for MDR-TB is usually **18–24 months**, making Option B the standard clinical protocol. **Why Other Options are Wrong:** * **Option A:** 4 months of IP and 12 months of CP is insufficient for MDR-TB; such short durations are associated with high relapse rates in resistant cases. * **Option C:** 4 months of CP is far too short. Even drug-sensitive TB requires at least 4 months of CP. * **Option D:** This represents the older "Category II" retreatment regimen (2S-H-R-Z-E / 1H-R-Z-E / 5H-R-E), which was used for "defaulters" or "relapse" cases, not specifically for confirmed MDR-TB. **High-Yield Clinical Pearls for NEET-PG:** * **MDR-TB:** Resistant to H + R. * **XDR-TB (Extensively Drug-Resistant):** MDR-TB + resistance to any **Fluoroquinolone** + at least one **second-line injectable** (Amikacin, Kanamycin, or Capreomycin). *Note: Newer definitions focus on resistance to Bedaquiline or Linezolid.* * **Bedaquiline:** Inhibits mycobacterial **ATP synthase**; it is a key component of newer, shorter MDR-TB regimens (9–11 months). * **Pre-XDR TB:** MDR-TB + resistance to either a fluoroquinolone or a second-line injectable (but not both).

Question 363: Which anti-tuberculosis drug can cause an eye defect?

A. Ethambutol (Correct Answer)
B. Pyrazinamide
C. Rifampicin
D. Isoniazid

Explanation: **Explanation:** **Ethambutol (Option A)** is the correct answer because its most characteristic and dose-dependent side effect is **Retrobulbar Neuritis**. This condition typically manifests as a decrease in visual acuity, central scotomas, and a loss of **red-green color discrimination**. The underlying mechanism involves the chelation of copper, which interferes with mitochondrial function in the optic nerve. Because of this risk, patients starting Ethambutol should undergo a baseline visual acuity and color vision test (Snellen and Ishihara charts). **Why other options are incorrect:** * **Pyrazinamide (Option B):** Its most significant side effects are hepatotoxicity and **hyperuricemia** (which can precipitate acute gouty arthritis) by inhibiting the renal excretion of uric acid. * **Rifampicin (Option C):** Known for causing a harmless **orange-red discoloration** of body fluids (urine, sweat, tears). Its serious side effects include hepatotoxicity and a "flu-like syndrome" with intermittent dosing. * **Isoniazid (Option D):** The hallmark side effects are **Peripheral Neuropathy** (due to Vitamin B6/Pyridoxine deficiency) and hepatotoxicity. It does not typically cause optic nerve defects. **High-Yield Clinical Pearls for NEET-PG:** * **Ethambutol** is the only bacteriostatic drug among the first-line ATT (RIPE). * It is contraindicated in children who are too young to undergo reliable visual testing. * **Mnemonic for Ethambutol:** "**E**" for "**E**ye" (Optic neuritis) and "**E**" for "**E**xcretion" (primarily renal; requires dose adjustment in renal failure). * **Visual changes** are usually reversible if the drug is discontinued promptly.

Question 364: Choose the most effective drug for mild intestinal amoebiasis and asymptomatic cyst passers.

A. Metronidazole
B. Emetine
C. Quiniodochlor
D. Diloxanide furoate (Correct Answer)

Explanation: **Explanation:** The treatment of amoebiasis depends on the site of infection. *Entamoeba histolytica* exists in two forms: motile trophozoites (invasive) and cysts (infective) [3]. **Why Diloxanide Furoate is correct:** Diloxanide furoate is a highly effective **luminal amoebicide** [1]. It acts directly in the bowel lumen to kill cysts and trophozoites. In asymptomatic cyst passers or mild intestinal cases, the infection is localized to the gut lumen [1]. Since Diloxanide furoate is poorly absorbed, it reaches high concentrations in the intestine, making it the drug of choice for eradicating the carrier state and preventing further transmission. **Why the other options are incorrect:** * **Metronidazole:** This is a **tissue amoebicide**. While it is the drug of choice for invasive disease (amoebic liver abscess or severe dysentery), it is less effective against luminal cysts [2]. It must always be followed by a luminal agent to ensure complete eradication [1]. * **Emetine:** This is a potent tissue amoebicide used only in severe, life-threatening cases due to its high toxicity (cardiotoxicity). It has no role in mild or asymptomatic cases. * **Quiniodochlor (Iodoquinol):** While it is a luminal amoebicide, it is less effective than Diloxanide furoate and carries a risk of subacute myelo-optic neuropathy (SMON) with prolonged use [1]. **NEET-PG High-Yield Pearls:** * **Classification:** Luminal amoebicides (Diloxanide furoate, Paromomycin, Iodoquinol) vs. Tissue amoebicides (Metronidazole, Tinidazole, Emetine, Chloroquine). * **Drug of Choice for Amoebic Liver Abscess:** Metronidazole followed by a luminal agent [2]. * **Drug of Choice for Asymptomatic Cyst Passers:** Diloxanide furoate or Paromomycin [1]. * **Paromomycin** is an aminoglycoside used as a luminal amoebicide and is also the drug of choice for visceral leishmaniasis in certain regimens.

Question 365: Voriconazole is used for all the diseases mentioned below except?

A. Aspergillosis
B. Candida albicans
C. Candida tropicalis
D. Mucoromycosis (Correct Answer)

Explanation: **Explanation:** Voriconazole is a second-generation triazole and a derivative of fluconazole. It is the **drug of choice for Invasive Aspergillosis**. However, it is notoriously ineffective against the order Mucorales, which causes **Mucormycosis**. **1. Why Mucormycosis is the correct answer:** Voriconazole lacks activity against *Rhizopus*, *Mucor*, and *Lichtheimia* species. In fact, prolonged use of voriconazole in immunocompromised patients is a known risk factor for the development of "breakthrough" Mucormycosis. The drugs of choice for Mucormycosis are **Amphotericin B** (Liposomal) or newer azoles like **Isavuconazole** and **Posaconazole**. **2. Why the other options are incorrect:** * **Aspergillosis (Option A):** Voriconazole is the gold standard treatment for invasive aspergillosis, showing superior efficacy and better survival rates compared to Amphotericin B. * **Candida species (Options B & C):** Voriconazole has a broad spectrum against *Candida* species, including those resistant to fluconazole (like *Candida krusei* and some strains of *Candida glabrata*). It is highly effective against *C. albicans* and *C. tropicalis*. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Inhibits 14-α-demethylase, preventing ergosterol synthesis. * **Side Effects (High Yield):** 1. **Visual disturbances:** Photophobia and blurred vision (reversible). 2. **Neurological:** Hallucinations. 3. **Dermatological:** Photosensitivity and increased risk of squamous cell carcinoma. * **Metabolism:** Exhibits non-linear kinetics (zero-order) and is metabolized by CYP2C19. * **Drug of Choice Summary:** Voriconazole = Aspergillosis; Posaconazole/Amphotericin B = Mucormycosis.

Question 366: In the treatment protocol for TB meningitis, which of the following drugs is not used?

A. Streptomycin (Correct Answer)
B. Rifampicin
C. Ethambutol
D. Pyrazinamide

Explanation: **Explanation:** The primary factor determining the choice of drugs for **Tubercular Meningitis (TBM)** is their ability to cross the **Blood-Brain Barrier (BBB)** and achieve therapeutic concentrations in the Cerebrospinal Fluid (CSF). **Why Streptomycin is the correct answer:** Streptomycin is an aminoglycoside. These are highly polar, water-soluble molecules that exhibit **poor penetration** into the CNS, even when the meninges are inflamed. Due to its inability to reach effective bactericidal levels in the CSF and its potential for vestibulocochlear toxicity, it is not included in the standard intensive phase regimen for TBM. **Analysis of Incorrect Options:** * **Rifampicin:** Although it has moderate CSF penetration (about 10-20% of plasma levels), it is a cornerstone of TBM treatment due to its potent bactericidal action against intra-cellular bacilli. * **Ethambutol:** While it has poor penetration through intact meninges, its penetration **increases significantly (up to 25%) during inflammation**, making it a standard component of the initial 4-drug regimen (HRZE). * **Pyrazinamide:** This is the **most effective** drug in terms of CNS penetration. It reaches CSF concentrations nearly equal to plasma levels (90-100%) regardless of meningeal inflammation. **High-Yield Clinical Pearls for NEET-PG:** * **Best CSF Penetration:** Pyrazinamide and Isoniazid (INH). * **Standard Regimen:** The WHO and National guidelines recommend 2 months of **HRZE** (Intensive phase) followed by 7–10 months of **HR** (Continuation phase). * **Role of Steroids:** Dexamethasone or Prednisolone is mandatory in TBM to reduce cerebral edema and prevent complications like hydrocephalus and vasculitis. * **Second-line drugs with good CNS penetration:** Ethionamide, Cycloserine, and Fluoroquinolones (Levofloxacin).

Question 367: What is the drug of choice for herpes zoster?

A. Acyclovir
B. Idoxuridine
C. Ganciclovir
D. Valaciclovir (Correct Answer)

Explanation: **Explanation:** The drug of choice for **Herpes Zoster (Shingles)** is **Valaciclovir**. While Acyclovir is effective, Valaciclovir is preferred due to its superior pharmacokinetic profile. It is a prodrug of acyclovir with significantly higher oral bioavailability (approx. 55% vs. 15-20% for acyclovir). This allows for less frequent dosing (thrice daily compared to five times daily for acyclovir), leading to better patient compliance and more consistent plasma concentrations, which are crucial for treating the more resistant Varicella-Zoster Virus (VZV). **Analysis of Options:** * **Acyclovir:** Although active against VZV, it requires high doses (800 mg 5x/day) due to poor absorption. It remains the drug of choice for *Herpes Simplex Encephalitis* (IV) and *Genital Herpes*. * **Idoxuridine:** A pyrimidine analogue that is too toxic for systemic use. It is used only topically, primarily for *Herpetic Keratitis*. * **Ganciclovir:** This is the drug of choice for **Cytomegalovirus (CMV)** infections. It is more toxic (bone marrow suppression) and is not indicated for routine Herpes Zoster. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** These drugs are phosphorylated to active triphosphate forms by **Viral Thymidine Kinase**. * **Famciclovir:** Another preferred oral prodrug (of penciclovir) for Zoster, similar in efficacy to Valaciclovir. * **Post-Herpetic Neuralgia (PHN):** Early treatment with Valaciclovir (within 72 hours) reduces the duration of PHN. * **Foscarnet:** Drug of choice for acyclovir-resistant HSV or VZV (does not require viral kinase for activation).

Question 368: Which of the following is NOT a protease inhibitor?

A. Nelfinavir
B. Saquinavir
C. Ritonavir
D. Abacavir (Correct Answer)

Explanation: **Explanation:** The question asks to identify the drug that does not belong to the **Protease Inhibitor (PI)** class of antiretroviral therapy (ART). **1. Why Abacavir is the correct answer:** Abacavir is a **Nucleoside Reverse Transcriptase Inhibitor (NRTI)**. It works by competitively inhibiting the viral enzyme reverse transcriptase and acting as a chain terminator during DNA synthesis. Unlike Protease Inhibitors, it does not act on the viral assembly stage. * **High-Yield Fact:** Abacavir is uniquely associated with a severe **hypersensitivity reaction** linked to the **HLA-B*5701** allele. Screening for this allele is mandatory before initiation. **2. Why the other options are incorrect:** * **Nelfinavir, Saquinavir, and Ritonavir** are all Protease Inhibitors. * **Mechanism of Action:** PIs inhibit the viral protease enzyme (encoded by the *pol* gene), preventing the cleavage of the Gag-Pol polyprotein precursor into functional structural proteins. This results in the production of immature, non-infectious virions. * **Mnemonic:** Most Protease Inhibitors end with the suffix **"-navir"** (e.g., Atazanavir, Darunavir, Lopinavir). **3. Clinical Pearls for NEET-PG:** * **Ritonavir:** It is rarely used for its own antiviral effect but is used as a **"pharmacokinetic booster."** It is a potent inhibitor of CYP3A4, which increases the plasma concentration and half-life of other PIs (e.g., Lopinavir + Ritonavir). * **Metabolic Side Effects:** PIs are notoriously associated with **lipodystrophy** (buffalo hump), hyperlipidemia, insulin resistance (hyperglycemia), and spontaneous bleeding in hemophiliacs. * **Indinavir:** Specifically associated with **nephrolithiasis** (crystalluria); patients must maintain high hydration.

Question 369: Which of the following agents is safest for treating chloroquine-resistant malaria in a 26-year-old primigravida?

A. Mefloquine
B. Pyrimethamine
C. Proguanil
D. Quinine plus clindamycin (Correct Answer)

Explanation: **Explanation:** The treatment of malaria in pregnancy requires balancing efficacy with fetal safety. For a **26-year-old primigravida** (first-time pregnant woman) with chloroquine-resistant *P. falciparum* malaria, the drug of choice depends on the trimester. **Why Quinine plus Clindamycin is correct:** According to WHO and National Guidelines, **Quinine plus Clindamycin** is the preferred treatment for chloroquine-resistant malaria in the **first trimester** of pregnancy. Quinine is considered safe throughout pregnancy, though it may cause hypoglycemia (due to insulin secretion). Clindamycin is used as an adjunct to avoid the fetal bone and teeth toxicity associated with Tetracyclines/Doxycycline, which are otherwise standard partners for Quinine in non-pregnant adults. **Analysis of Incorrect Options:** * **Mefloquine (A):** While used for prophylaxis, it is generally avoided for treatment in the first trimester unless no other options are available due to concerns regarding neuropsychiatric side effects and limited safety data in early pregnancy. * **Pyrimethamine (B) & Proguanil (C):** These are antifolate agents. Pyrimethamine is potentially teratogenic in the first trimester (folate deficiency). Proguanil is rarely used alone for treatment due to high resistance rates; they are typically used as prophylaxis or in combination (e.g., Atovaquone-Proguanil, which is avoided in the first trimester). **NEET-PG High-Yield Pearls:** * **First Trimester:** Quinine + Clindamycin is the gold standard. * **Second & Third Trimesters:** ACT (Artemisinin-based Combination Therapy) is the treatment of choice. * **Severe Malaria in Pregnancy:** Intravenous **Artesunate** is the drug of choice in all trimesters, as the benefits of saving the mother’s life outweigh potential fetal risks. * **Side Effect Note:** Monitor for **hypoglycemia** when administering Quinine to pregnant patients.

Question 370: Allopurinol acts by which mechanism?

A. Inhibiting synthesis of uric acid (Correct Answer)
B. Inhibiting purine synthesis
C. Inhibiting pyrimidine synthesis
D. Inhibiting conversion of xanthine to hypoxanthine

Explanation: ### Explanation **Correct Option: A. Inhibiting synthesis of uric acid** Allopurinol is a structural analog of hypoxanthine [1], [2]. It acts as a potent **competitive inhibitor of Xanthine Oxidase (XO)** [1], [2], the enzyme responsible for the final two steps of purine catabolism: the conversion of hypoxanthine to xanthine and xanthine to **uric acid** [1], [2]. By blocking this enzyme, allopurinol effectively lowers serum and urinary uric acid levels, making it the drug of choice for chronic gout and hyperuricemia [1], [2]. **Analysis of Incorrect Options:** * **B & C: Inhibiting purine/pyrimidine synthesis:** Allopurinol does not inhibit the *de novo* synthesis of purines or pyrimidines. While its metabolite (oxypurinol) can slightly influence the salvage pathway, its primary therapeutic effect is on the **degradation** pathway, not synthesis [2]. * **D. Inhibiting conversion of xanthine to hypoxanthine:** This is the reverse of the actual physiological process. Xanthine oxidase converts hypoxanthine → xanthine → uric acid. Allopurinol inhibits this forward progression [1]. **NEET-PG Clinical Pearls:** * **Active Metabolite:** Allopurinol is converted by xanthine oxidase into **Alloxanthine (Oxypurinol)**, which is a non-competitive, long-acting inhibitor of the same enzyme (Suicide inhibition) [1], [2], [3]. * **Drug Interactions:** Since **6-Mercaptopurine (6-MP)** and **Azathioprine** are metabolized by xanthine oxidase, co-administration with allopurinol leads to toxic levels of these drugs. Reduce their dose by 75%. * **Hypersensitivity:** Watch for **HLA-B*5801** association with Allopurinol-induced Stevens-Johnson Syndrome (SJS), especially in Asian populations. * **Acute Gout:** Never start allopurinol during an acute attack, as a sudden drop in urate levels can mobilize crystals and worsen the inflammation [2].

Practice by Chapter

Beta-Lactam Antibiotics

Practice Questions

Aminoglycosides

Practice Questions

Macrolides and Ketolides

Practice Questions

Tetracyclines

Practice Questions

Quinolones

Practice Questions

Sulfonamides and Trimethoprim

Practice Questions

Antimycobacterial Drugs

Practice Questions

Antifungal Agents

Practice Questions

Antiviral Drugs

Practice Questions

Antiparasitic Agents

Practice Questions

Principles of Antimicrobial Selection

Practice Questions

Antimicrobial Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free